BMS-backed Arsenal Bio pulls trigger on $220M series B, touting potential fleet of...

cafead

Administrator
Staff member
  • cafead   Sep 06, 2022 at 10:52: AM
via Arsenal Bio is jumping headfirst into the cell therapy arena, and its latest fundraising haul, backed in part by Bristol Myers Squibb, is making a significant splash.

article source
 

<